Dissolution characteristics of nifedipine complexes with β-cyclodextrins

Drug Development and Industrial Pharmacy

Volumn 22, Issue 12, 1996, Pages 1231-1236

  Becirevic Lacan M ^a   Filipovic Grcic J ^a   Skalko N ^a   Jalsenjak J ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; NIFEDIPINE;

ARTICLE; COMPLEX FORMATION; DISSOLUTION; DRUG SOLUBILITY; SOLUBILIZATION;

EID: 0029802747     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049609063242     Document Type: Article

References (11)

1. J. Szejtli, Cyclodextrins in drug formulations: Part I, Pharm. Tehn. Int., 3, 15 (1991).
2. Z. Wang, F. Hirayama, K. Ikegami, and K. Uekama, Chem. Pharm. Bull., 41, 1822 (1993).
3. K. Uekama, K. Ikegami, Z. Wang, Y. Horinuchi, and F. Hirayama, K-30, J. Pharm. Pharmacol., 44, 73 (1992).
4. Z. Wang, F. Horikawa, F. Hirayama, and K. Uekama, J. Pharm. Pharmacol., 45, 942 (1993).
5. Z. Wang, F. Hirayama, and K. Uekama, J. Pharm. Pharmacol., 46, 505 (1994).
6. K. Uekama, K. Matsubara, K. Abe, Y. Horinchi, F. Hirayama, and N. Suzuki, Pharm. Sci., 79, 244 (1990).
7. K. Uekama, T. Imai, T. Maeda, T. Irie, F. Hirayama, and M. Otagiri, J. Pharm. Sci., 74, 841 (1985).
8. T. Loftsson, H. Fridriksdottir, A. M. Sigurdardottir, and H. Ueda, Int. J. Pharm., 110, 169 (1994).
9. T. Higuchi and K. A. Connors, Adv. Anal. Chem. Instr., 4, 117 (1965).
10. M. Bećirević, N. Kallay, and R. Senjković, Pharmazie, 43, 544 (1988).
11. B. W. Müller and U. Brauns, J. Pharm. Sci., 75, 571 (1986).